San Diego genetic-sequencing pioneer Illumina on Monday challenged Carl Icahn’s bid for control, saying the billionaire activist investor’s board candidates “lack relevant skills.”
San Diego genetic-sequencing pioneer Illumina on Monday challenged Carl Icahn’s bid for control, saying the billionaire activist investor’s board candidates “lack relevant skills.”
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.
